Zuzana Kubova
Overview
Explore the profile of Zuzana Kubova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrackova A, Manakova J, Nesnadna R, Kubova Z, Papajik T, Kriegova E
Cancer Commun (Lond)
. 2025 Mar;
PMID: 40071743
No abstract available.
2.
Chatzikonstantinou T, Scarfo L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al.
Hemasphere
. 2024 Sep;
8(9):e70004.
PMID: 39290716
No abstract available.
3.
Szanyi J, Kremlacek J, Kubova Z, Kuba M, Vit F, Langrova J, et al.
Doc Ophthalmol
. 2024 Apr;
148(3):155-166.
PMID: 38622306
Purpose: The aim of this neurophysiological study was to retrospectively analyze visual evoked potentials (VEPs) acquired during an examination for diagnosing optic nerve involvement in patients with Lyme neuroborreliosis (LNB)....
4.
Kuba M, Kremlacek J, Vit F, Masopust J, Hubenak J, Kubova Z, et al.
Psychiatry Res Neuroimaging
. 2023 Dec;
337:111768.
PMID: 38128365
Despite positive prior results obtained by using event-related potentials (ERPs) in psychiatric patients, they are not routinely used in the clinical setting. This may in part be due to problems...
5.
Chatzikonstantinou T, Scarfo L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al.
EClinicalMedicine
. 2023 Nov;
65:102307.
PMID: 38033506
Background: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed...
6.
Kuba M, Kremlacek J, Vit F, Kubova Z, Langrova J, Szanyi J, et al.
Doc Ophthalmol
. 2022 Nov;
146(1):79-91.
PMID: 36436114
Introduction: We developed a new portable device called "VEPpeak" for the examination of visual evoked potentials (VEPs) to extend VEP examination beyond specialized electrophysiological laboratories and to simplify the use...
7.
Manukyan G, Mikulkova Z, Turcsanyi P, Savara J, Trajerova M, Kubova Z, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638404
Chronic lymphocytic leukaemia (CLL) is a genetically, morphologically and phenotypically heterogeneous chronic disease with clinical variability between patients. Whether the significant heterogeneity of cell size within the CLL population contributes...
8.
Kremlacek J, Nekolova J, Stredova M, Langrova J, Szanyi J, Kuba M, et al.
Doc Ophthalmol
. 2021 Jan;
143(1):17-31.
PMID: 33392893
Background: For patients with age-related macular degeneration (AMD), a special intraocular lens implantation partially compensates for the loss in the central part of the visual field. For six months, we...
9.
Smolej L, Turcsanyi P, Kubova Z, Zuchnicka J, Mihalyova J, Simkovic M, et al.
Br J Haematol
. 2020 Dec;
193(1):133-137.
PMID: 33280081
Most patients with chronic lymphocytic leukaemia (CLL) are nowadays diagnosed without any symptoms and do not require therapy. A prognostic score identifying patients within this large group who are at...
10.
Szanyi J, Kremlacek J, Kubova Z, Kuba M, Gebousky P, Kapla J, et al.
Doc Ophthalmol
. 2019 Apr;
139(2):83-97.
PMID: 30993574
Purpose: The aim of this neurophysiological study was to monitor changes in the visual and cognitive function of HIV-infected patients treated with combination antiretroviral therapy. Methods: Eleven adult Czech HIV+...